Gland Pharma Limited (BOM:543245)
India
· Delayed Price · Currency is INR 1,464.20
+15.95 (1.10%)
At close: Apr 21, 2025
Gland Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 17, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2017 - 2019 |
| Market Capitalization | 241,451 | 303,932 | 208,882 | 537,705 | 405,432 | - | Upgrade
|
| Market Cap Growth | -7.51% | 45.50% | -61.15% | 32.63% | - | - | Upgrade
|
| Enterprise Value | 216,516 | 286,055 | 175,977 | 508,469 | 390,204 | - | Upgrade
|
| Last Close Price | 1465.50 | 1823.10 | 1255.65 | 3235.79 | 2452.52 | - | Upgrade
|
| PE Ratio | 34.28 | 39.35 | 26.74 | 44.38 | 40.67 | - | Upgrade
|
| PS Ratio | 4.21 | 5.37 | 5.76 | 12.22 | 11.71 | - | Upgrade
|
| PB Ratio | 2.75 | 3.48 | 2.63 | 7.51 | 6.87 | - | Upgrade
|
| P/TBV Ratio | 2.87 | 3.63 | 2.63 | 7.53 | 6.87 | - | Upgrade
|
| P/FCF Ratio | - | 50.08 | 146.03 | 192.42 | 107.78 | - | Upgrade
|
| P/OCF Ratio | - | 30.49 | 57.39 | 68.00 | 67.02 | - | Upgrade
|
| EV/Sales Ratio | 3.78 | 5.05 | 4.86 | 11.55 | 11.27 | - | Upgrade
|
| EV/EBITDA Ratio | 15.64 | 21.77 | 17.07 | 33.67 | 29.97 | - | Upgrade
|
| EV/EBIT Ratio | 23.92 | 28.94 | 19.90 | 36.32 | 32.42 | - | Upgrade
|
| EV/FCF Ratio | - | 47.14 | 123.03 | 181.96 | 103.74 | - | Upgrade
|
| Debt / Equity Ratio | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.24 | 0.28 | 0.00 | 0.00 | 0.00 | 0.01 | Upgrade
|
| Debt / FCF Ratio | - | 0.61 | 0.03 | 0.02 | 0.01 | 0.01 | Upgrade
|
| Asset Turnover | - | 0.58 | 0.44 | 0.61 | 0.65 | 0.69 | Upgrade
|
| Inventory Turnover | - | 1.40 | 1.16 | 1.79 | 1.56 | 1.44 | Upgrade
|
| Quick Ratio | - | 2.61 | 6.58 | 7.80 | 7.31 | 5.50 | Upgrade
|
| Current Ratio | - | 4.04 | 9.46 | 10.06 | 10.00 | 7.93 | Upgrade
|
| Return on Equity (ROE) | - | 9.26% | 10.33% | 18.55% | 20.88% | 23.75% | Upgrade
|
| Return on Assets (ROA) | - | 6.36% | 6.65% | 12.21% | 14.22% | 14.14% | Upgrade
|
| Return on Capital (ROIC) | 6.37% | 7.24% | 7.31% | 13.39% | 15.73% | 16.50% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 10.70% | 11.00% | 19.30% | 20.10% | 23.10% | Upgrade
|
| Earnings Yield | 2.92% | 2.54% | 3.74% | 2.25% | 2.46% | - | Upgrade
|
| FCF Yield | - | 2.00% | 0.69% | 0.52% | 0.93% | - | Upgrade
|
| Dividend Yield | 1.37% | 1.10% | - | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.01% | -0.03% | -0.09% | -3.96% | -2.15% | - | Upgrade
|
| Total Shareholder Return | 1.36% | 1.06% | -0.09% | -3.96% | -2.15% | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.